Abstract
Background Oral squamous cell carcinoma (OSCC) is the most common oral malignancy, often associated with poor outcomes due to metastasis and late detection. The epithelial-to-mesenchymal transition (EMT) is central to OSCC progression, but the prognostic role of EMT markers remains unclear. This systematic review and meta-analysis evaluated five key EMT markers-E-cadherin, EpCAM, Vimentin, TWIST, and SNAIL-in OSCC. Methods Following PRISMA guidelines, studies were retrieved from PubMed, Scopus, Embase, ClinicalTrials.gov, and Google Scholar up to May 2025. Pooled odds ratios (OR) and hazard ratios (HR) with 95% confidence intervals (CI) were calculated using RevMan 5.4.1 Heterogeneity was assessed by the I2 index, and fixed- or random-effects models were applied. Results Seventy-three observational studies were included. Vimentin showed the strongest prognostic effect, being significantly associated with lymph node metastasis (OR = 11.84, 95% CI 7.56–18.53, p < 0.00001), advanced TNM stage (OR = 6.88, p < 0.00001), poor differentiation (OR = 7.37, p < 0.00001), and poor overall survival (HR = 5.09, p < 0.00001). TWIST (HR = 4.96, p < 0.00001) and SNAIL (HR = 2.06, p = 0.0003) were also strongly predictive of aggressive clinicopathological features and worse survival. Loss of E-cadherin correlated with poor differentiation (OR = 2.80, p < 0.00001) and reduced disease-free survival (RR = 0.80, p = 0.0005), though its effect on overall survival was inconsistent. EpCAM expression showed context-dependent roles, with high expression linked to advanced stage and poor OS, whereas low expression predicted poor differentiation. Overall, Vimentin and TWIST consistently emerged as the strongest predictors of adverse outcomes, while preserved E-cadherin was protective. Conclusion Vimentin, TWIST, and SNAIL are strong predictors of aggressive disease and poor survival in OSCC, while preserved E-cadherin is protective. EMT markers hold promise for prognostic assessment and precision management in OSCC. Graphical abstract
Funding Information
  • Council of Scientific and Industrial Research, India (UGC-Ref. No.; 791/ (CSIR-UGC NET), 10th December 2019.)

This publication has 102 references indexed in Scilit: